NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
NASDAQ: BYND 32.83%
Expected US Company Earnings on Wednesday, February 25th, 2026
NYSE: KORE 77.39%
KORE Reports Third Quarter 2025 Results
NASDAQ: CDIO 32.65%
BioMedNewsBreaks - Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) Schedules Investor Conference Call for Feb. 19, 2026
NASDAQ: MGN 34.5%
Megan Holdings Limited Announces Closing of $8.3 Million Follow-on Public Offering
NYSE: BATL 21.08%
Halftime Market Summary: Stocks to Watch before Super Bowl Weekend
NYSE: NGNE 32.83%
NYSE: BYND 32.83%
NYSE: KORE 32.83%
NYSE: CDIO 32.83%
NYSE: MGN 32.83%
